Showing 2 posts of 2 posts found.
Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with …
Bayer has stopped the commercial sale of a sterilisation device in all countries, except the US, after reports that it …
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO